封面
市场调查报告书
商品编码
1951327

毛细管电泳市场 - 全球产业规模、份额、趋势、机会及预测(按组件、模式、应用、最终用户、地区和竞争格局划分),2021-2031年

Capillary Electrophoresis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By Mode, By Application, By End User, By Region & Competition, 2021-2031F

出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球毛细管电泳市场预计将从 2025 年的 4.0805 亿美元成长到 2031 年的 5.7621 亿美元,复合年增长率达到 5.92%。

此分析技术利用亚毫米级毛细管内的电压,根据离子的电泳迁移率分离离子。市场成长的主要驱动力是慢性病发病率的上升以及由此带来的个人化医疗需求,而个人化医疗需要精准的诊断工具来识别生物标记。此外,蓬勃发展的生物製药产业也越来越依赖这项技术,在生产过程中对单株抗体进行详细的表征和品管。这些根本性的驱动因素不同于小型化和与质谱联用等技术变革,因为它们反映的是推动技术应用的基本操作需求,而非方法本身的演进。

市场概览
预测期 2027-2031
市场规模:2025年 4.0805亿美元
市场规模:2031年 5.7621亿美元
复合年增长率:2026-2031年 5.92%
成长最快的细分市场 测量设备
最大的市场 北美洲

儘管市场呈现上升趋势,但由于缺乏熟练操作这些先进系统并能分析其所产生复杂数据的合格专业人员,市场仍面临许多挑战。这种专业技能的缺口会限制实验室的吞吐量,并减缓先进技术的应用。为了展现支撑这些技术的产业规模,主要产业协会的数据提供了有关生产产出的洞见。根据日本分析仪器製造商协会统计,2024年毛细管电泳所需的分离分析仪的产值将达到约648亿日圆。

市场驱动因素

製药和生技领域研发投入的不断成长是推动全球毛细管电泳市场发展的主要因素。随着产业朝向复杂生物製药(包括基因疗法和单株抗体)方向发展,对高解析度分析方法的需求日益增长,以检验药物的稳定性和纯度。毛细管电泳已成为表征这些高阶研发阶段的聚醣和电荷异质性的关键技术,促使企业对相关设备进行大量投资。主要产业参与者的巨额研发投入凸显了这种研发强度。强生公司报告称,截至2025年1月,其2024财年的研发支出为172亿美元,这证实了企业在采用先进工具进行药物研发方面投入了大量资金。

此外,技术进步,特别是微晶片毛细管电泳技术的兴起,突破了传统技术在灵敏度和通量方面的限制,加速了市场扩张。这些创新实现了快速分离和与质谱的有效整合,为现代蛋白质体学和基因组学研究提供了至关重要的能力。这些微型化装置的效率提升使得生物标记的侦测更加精准。例如,2025年1月发表于《色谱杂誌A》(Journal of Chromatography A)的一篇题为「微晶片毛细管电泳-质谱联用技术用于高通量同时分析B族维生素」的论文详细介绍了一种新的微晶片方法,该方法实现了低于4 ppb的检测极限和低于3分钟的分离时间。作为支撑这些进步的广泛产业环境的例证,Bio-Rad Laboratories在2025年报告称,其生命科学部门2024年全年净销售额达到10.3亿美元,凸显了临床和研究仪器市场的巨大规模。

市场挑战

合格人员短缺是限制全球毛细管电泳市场成长的一大障碍。与更基础的分析技术相比,毛细管电泳需要操作人员具备专门的技术技能,才能进行方法开发、选择合适的缓衝液并解读复杂的资料集。当实验室缺乏具备此类专业知识的人员时,就会面临操作瓶颈,导致样本处理量下降,分析误差增加。这种人力资源的匮乏直接阻碍了机构购买新设备,因为如果没有合格的管理人员,仪器就无法发挥其全部潜力,从而有效地阻止了资本采购。

人才短缺的影响因全球范围内大量技术系统的分布而加剧,导致对专业人才的需求超过了目前的劳动力供应。随着製造商将这些先进仪器出口到国际市场,对本地培训的操作人员的需求也随之增加。例如,日本分析仪器製造商协会的数据显示,2024年分离和分析设备的出口额约为373亿日元,凸显了技术的全球流动。如此巨大的出口量表明,先进诊断工具的供应与能够操作这些工具的合格人员数量之间存在脱节,这从根本上限制了市场的实际成长潜力。

市场趋势

与传统的蛋白质表征不同,毛细管电泳市场在基因治疗领域实现了向病毒载体和质体DNA分析的多元化发展,这标誌着该领域的重大变革。随着生物製药产业加速开发细胞和基因疗法,其越来越依赖毛细管电泳技术来精确分离超螺旋质体DNA和线性异构体,并确定病毒衣壳的包装状态。这项应用对于检验复杂基因药物的有效性和安全性至关重要,并且需要先进的分析基础设施。支援这些工作流程的仪器投资巨大。根据赛默飞世尔科技公司于2025年1月发布的「2024年第四季及全年业绩」新闻稿,该公司分析仪器部门(为这些治疗方法的研发提供支援)仅在2024年第四季就累计了21.9亿美元的收入。

同时,市场趋势正推动毛细管电泳工作流程朝向全自动、高通量方向显着转变,以提高实验室的重复性和效率。研究实验室正逐渐从手动凝胶技术和单毛细管系统转向并行处理平台,这些平台能够以最少的操作人员干预同时分析大量样品。这种转变的驱动力在于优化品管程式并快速产生用于大规模筛检的数位资料,从而减少人为错误和操作延迟。主要仪器供应商的财务表现也印证了对这类自动化解决方案的强劲需求。岛津公司于2025年2月宣布,其分析测量仪器业务截至2024年12月31日的九个月净销售额约为2,479亿日元,凸显了该产业对先进、高效分离技术的持续依赖。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章:客户评价

第五章 全球毛细管电泳市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 按组件(仪器、耗材、软体)
    • 透过方法(毛细管区带电泳、毛细管层析法等)
    • 透过应用(核酸分析和蛋白质分析)
    • 依最终用户(生技/製药公司、临床检查室、学术/研究机构、其他)划分
    • 按地区
    • 按公司(2025 年)
  • 市场地图

6. 北美毛细管电泳市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲:国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲毛细管电泳市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲:国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区毛细管电泳市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东和非洲毛细管电泳市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲:国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章:南美洲毛细管电泳市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲:国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球毛细管电泳市场:SWOT分析

第十四章:波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc
  • Merck KGaA
  • Promega Corporation
  • Shimadzu Corporation
  • LABGENE Scientific SA

第十六章 策略建议

第十七章:关于研究公司及免责声明

简介目录
Product Code: 12992

The Global Capillary Electrophoresis Market is projected to expand from USD 408.05 Million in 2025 to USD 576.21 Million by 2031, achieving a compound annual growth rate of 5.92%. This analytical technique utilizes applied voltage within a submillimeter diameter capillary tube to separate ions based on their electrophoretic mobility. Market momentum is primarily generated by the increasing incidence of chronic diseases and the resulting need for personalized medicine, which requires accurate diagnostic tools for identifying biomarkers. Additionally, the growing biopharmaceutical sector depends heavily on this technology for detailed monoclonal antibody characterization and quality control during manufacturing. These foundational drivers are differentiated from technological shifts like miniaturization or mass spectrometry integration, as they reflect the fundamental operational necessities driving adoption rather than the evolution of the method itself.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 408.05 Million
Market Size 2031USD 576.21 Million
CAGR 2026-20315.92%
Fastest Growing SegmentInstruments
Largest MarketNorth America

Despite this upward trend, the market encounters a major obstacle due to a scarcity of qualified professionals skilled in operating these sophisticated systems and analyzing the complex data they yield. This expertise gap can restrict laboratory throughput and slow the uptake of advanced techniques. To demonstrate the industrial magnitude of the sector backing these technologies, data from leading trade associations offers perspective on manufacturing output. According to the Japan Analytical Instruments Manufacturers' Association, the production value of separation analysis apparatus, a category pivotal to capillary electrophoresis, reached approximately 64.8 billion JPY in 2024.

Market Driver

The increasing expenditure on research and development within the pharmaceutical and biotechnology sectors serves as a principal catalyst for the global capillary electrophoresis market. As the industry pivots toward complex biologics, including gene therapies and monoclonal antibodies, there is a heightened requirement for high-resolution analytical methods to verify drug stability and purity. Capillary electrophoresis has become essential for glycan analysis and characterizing charge heterogeneity during these advanced development stages, triggering substantial investment in required equipment. The scale of this research intensity is highlighted by the financial outlays of major industry participants; according to Johnson & Johnson, the company recorded $17.2 billion in research and development expenses for the full year 2024 in January 2025, underscoring the massive capital devoted to adopting sophisticated tools for drug discovery.

Furthermore, technological progress, specifically the rise of microchip-based capillary electrophoresis, is expediting market expansion by overcoming previous constraints regarding sensitivity and throughput. These innovations facilitate rapid separation times and effective integration with mass spectrometry, capabilities that are vital for contemporary proteomics and genomics research. The improved efficiency of these miniaturized units allows for more accurate biomarker detection. For instance, according to the Journal of Chromatography A in January 2025, an article titled 'Microchip capillary electrophoresis-mass spectrometry for high-throughput simultaneous analysis of B-complex vitamins' detailed a new microchip method that achieved detection limits below 4 ppb and separation times under three minutes. To demonstrate the wider industrial environment supporting these advancements, Bio-Rad Laboratories reported full-year 2024 net sales of $1.03 billion for its Life Science segment in 2025, emphasizing the substantial market size for clinical and research instrumentation.

Market Challenge

A scarcity of qualified personnel acts as a severe impediment to the growth of the Global Capillary Electrophoresis Market. In contrast to more basic analytical techniques, capillary electrophoresis demands operators who possess specialized technical skills to handle method development, select appropriate buffers, and interpret complex datasets. When laboratories are deficient in staff with this necessary expertise, they face operational obstructions that diminish sample throughput and heighten the probability of analytical inaccuracies. This gap in human resources directly discourages organizations from purchasing new instrumentation, as the equipment cannot be deployed to its full potential without capable supervision, effectively halting capital procurement.

The consequences of this workforce shortage are exacerbated by the large quantity of technical systems being distributed on a global scale, creating a need for expertise that exceeds the current labor supply. As manufacturers export these sophisticated instruments to international markets, the local requirement for trained operators escalates. Highlighting this global flow of technology, the Japan Analytical Instruments Manufacturers' Association reported that the export value of separation analysis apparatus stood at roughly 37.3 billion JPY in 2024. This substantial export volume underscores a growing disconnect between the provision of advanced diagnostic tools and the population of qualified experts available to run them, essentially constraining the market's practical growth potential.

Market Trends

The diversification into viral vector and plasmid DNA analysis for gene therapies marks a significant evolution in the capillary electrophoresis market, differing from standard protein characterization. As the biopharmaceutical industry hastens the development of cell and gene therapies, there is an increasing reliance on capillary electrophoresis to accurately separate supercoiled plasmid DNA from linear isoforms and distinguish between full and empty viral capsids. This application is crucial for validating the efficacy and safety of intricate genetic medicines, necessitating the installation of sophisticated analytical infrastructure. The magnitude of investment in the instrumentation underpinning these workflows is considerable; according to Thermo Fisher Scientific's January 2025 press release regarding Fourth Quarter and Full Year 2024 Results, their Analytical Instruments segment, which supports the creation of these therapies, generated $2.19 billion in revenue for the fourth quarter of 2024 alone.

Simultaneously, the market is experiencing a definitive transition toward fully automated, high-throughput capillary electrophoresis workflows to enhance laboratory reproducibility and efficiency. Laboratories are abandoning manual gel-based techniques and single-capillary systems in favor of parallel processing platforms capable of analyzing numerous samples concurrently with limited operator involvement. This shift is driven by the necessity to optimize quality control procedures and produce rapid, digital data for large-scale screening, thereby reducing human error and operational delays. The strong demand for such automated solutions is evident in the financial results of major equipment suppliers; according to Shimadzu Corporation in February 2025, the Analytical & Measuring Instruments segment reached net sales of approximately 247.9 billion JPY for the nine months ended December 31, 2024, emphasizing the sustained industrial dependence on advanced, high-efficiency separation technologies.

Key Market Players

  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc
  • Merck KGaA
  • Promega Corporation
  • Shimadzu Corporation
  • LABGENE Scientific SA

Report Scope

In this report, the Global Capillary Electrophoresis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Capillary Electrophoresis Market, By Component

  • Instruments
  • Consumables
  • Software

Capillary Electrophoresis Market, By Mode

  • Capillary Zone Electrophoresis
  • Capillary Electro Chromatography
  • Others

Capillary Electrophoresis Market, By Application

  • Nucleic Acid Analysis and Protein Analysis

Capillary Electrophoresis Market, By End User

  • Biotechnology & Pharmaceutical Companies
  • Clinical Laboratories
  • Academic & Research Institutions
  • Others

Capillary Electrophoresis Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Capillary Electrophoresis Market.

Available Customizations:

Global Capillary Electrophoresis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Capillary Electrophoresis Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Instruments, Consumables, Software)
    • 5.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 5.2.3. By Application (Nucleic Acid Analysis and Protein Analysis)
    • 5.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Capillary Electrophoresis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Mode
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Capillary Electrophoresis Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Mode
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Capillary Electrophoresis Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Mode
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Capillary Electrophoresis Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Mode
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Capillary Electrophoresis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Mode
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Capillary Electrophoresis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Mode
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. France Capillary Electrophoresis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Mode
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Capillary Electrophoresis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Mode
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Capillary Electrophoresis Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Mode
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Capillary Electrophoresis Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Mode
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia Pacific Capillary Electrophoresis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Mode
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Capillary Electrophoresis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Mode
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Capillary Electrophoresis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Mode
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Capillary Electrophoresis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Mode
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Capillary Electrophoresis Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Mode
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Capillary Electrophoresis Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Mode
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Middle East & Africa Capillary Electrophoresis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Mode
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Capillary Electrophoresis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Mode
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Capillary Electrophoresis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Mode
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Capillary Electrophoresis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Mode
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Capillary Electrophoresis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Mode
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Capillary Electrophoresis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Mode
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Capillary Electrophoresis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Mode
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Capillary Electrophoresis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Mode
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Capillary Electrophoresis Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. QIAGEN N.V.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific Inc.
  • 15.3. Agilent Technologies, Inc.
  • 15.4. Bio-Rad Laboratories, Inc.
  • 15.5. Danaher Corporation
  • 15.6. PerkinElmer, Inc
  • 15.7. Merck KGaA
  • 15.8. Promega Corporation
  • 15.9. Shimadzu Corporation
  • 15.10. LABGENE Scientific SA

16. Strategic Recommendations

17. About Us & Disclaimer